Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.98
SIAL's Cash to Debt is ranked higher than
74% of the 989 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.68 vs. SIAL: 1.98 )
SIAL' s 10-Year Cash to Debt Range
Min: 0.08   Max: 6.52
Current: 1.98

0.08
6.52
Equity to Asset 0.76
SIAL's Equity to Asset is ranked higher than
86% of the 989 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.56 vs. SIAL: 0.76 )
SIAL' s 10-Year Equity to Asset Range
Min: 0.54   Max: 0.88
Current: 0.76

0.54
0.88
F-Score: 5
Z-Score: 10.89
M-Score: -2.48
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 24.45
SIAL's Operating margin (%) is ranked higher than
98% of the 969 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.76 vs. SIAL: 24.45 )
SIAL' s 10-Year Operating margin (%) Range
Min: 15.5   Max: 25.83
Current: 24.45

15.5
25.83
Net-margin (%) 18.16
SIAL's Net-margin (%) is ranked higher than
97% of the 969 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.76 vs. SIAL: 18.16 )
SIAL' s 10-Year Net-margin (%) Range
Min: 10.83   Max: 30.95
Current: 18.16

10.83
30.95
ROE (%) 16.96
SIAL's ROE (%) is ranked higher than
93% of the 961 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.54 vs. SIAL: 16.96 )
SIAL' s 10-Year ROE (%) Range
Min: 13.68   Max: 37.26
Current: 16.96

13.68
37.26
ROA (%) 12.90
SIAL's ROA (%) is ranked higher than
97% of the 974 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.39 vs. SIAL: 12.90 )
SIAL' s 10-Year ROA (%) Range
Min: 9.05   Max: 23.76
Current: 12.9

9.05
23.76
ROC (Joel Greenblatt) (%) 39.18
SIAL's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 970 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.99 vs. SIAL: 39.18 )
SIAL' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 18.08   Max: 41.11
Current: 39.18

18.08
41.11
Revenue Growth (%) 6.60
SIAL's Revenue Growth (%) is ranked higher than
70% of the 788 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.10 vs. SIAL: 6.60 )
SIAL' s 10-Year Revenue Growth (%) Range
Min: 0.4   Max: 16.1
Current: 6.6

0.4
16.1
EBITDA Growth (%) 8.00
SIAL's EBITDA Growth (%) is ranked higher than
76% of the 685 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.00 vs. SIAL: 8.00 )
SIAL' s 10-Year EBITDA Growth (%) Range
Min: 1.9   Max: 18
Current: 8

1.9
18
EPS Growth (%) 9.20
SIAL's EPS Growth (%) is ranked higher than
75% of the 635 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.20 vs. SIAL: 9.20 )
SIAL' s 10-Year EPS Growth (%) Range
Min: 0   Max: 19.7
Current: 9.2

0
19.7
» SIAL's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

SIAL Guru Trades in Q2 2013

John Burbank 20,000 sh (New)
Joel Greenblatt 8,137 sh (New)
Ray Dalio 3,227 sh (New)
Yacktman Focused Fund 944,000 sh (+94.88%)
Donald Yacktman 2,420,445 sh (+94.43%)
Yacktman Fund 1,096,000 sh (+94.29%)
Chuck Royce 18,246 sh (+89.16%)
Jim Simons 387,732 sh (+19.14%)
Bill Frels 10,950 sh (unchged)
First Pacific Advisors 3,900 sh (unchged)
Dodge & Cox 22,000 sh (unchged)
Vanguard Health Care Fund Sold Out
Murray Stahl 275,627 sh (-0.1%)
Ken Fisher 68,874 sh (-0.95%)
Jeremy Grantham 129,855 sh (-1.07%)
Chris Davis 274,691 sh (-4.62%)
Manning & Napier Advisors, Inc 73,950 sh (-91.98%)
» More
Q3 2013

SIAL Guru Trades in Q3 2013

Steven Cohen 4,171 sh (New)
Joel Greenblatt 18,393 sh (+126.04%)
Manning & Napier Advisors, Inc 123,090 sh (+66.45%)
Ken Fisher 76,239 sh (+10.69%)
Bill Frels 11,051 sh (+0.92%)
Murray Stahl 276,220 sh (+0.22%)
Yacktman Focused Fund 944,000 sh (unchged)
Yacktman Fund 1,096,000 sh (unchged)
Chuck Royce 18,246 sh (unchged)
John Burbank Sold Out
Ray Dalio Sold Out
Donald Yacktman 2,404,546 sh (-0.66%)
Jeremy Grantham 125,255 sh (-3.54%)
Dodge & Cox 21,000 sh (-4.55%)
Chris Davis 249,264 sh (-9.26%)
Jim Simons 342,432 sh (-11.68%)
First Pacific Advisors 2,900 sh (-25.64%)
» More
Q4 2013

SIAL Guru Trades in Q4 2013

Joel Greenblatt 41,710 sh (+126.77%)
Steven Cohen 6,732 sh (+61.4%)
Bill Frels 11,064 sh (+0.12%)
Dodge & Cox 21,000 sh (unchged)
Yacktman Focused Fund 944,000 sh (unchged)
Yacktman Fund 1,096,000 sh (unchged)
First Pacific Advisors 2,900 sh (unchged)
Donald Yacktman 2,403,515 sh (-0.04%)
Manning & Napier Advisors, Inc 121,060 sh (-1.65%)
Ken Fisher 74,589 sh (-2.16%)
Jeremy Grantham 121,936 sh (-2.65%)
Chris Davis 239,465 sh (-3.93%)
Murray Stahl 246,858 sh (-10.63%)
Chuck Royce 14,000 sh (-23.27%)
Jim Simons 206,600 sh (-39.67%)
» More
Q1 2014

SIAL Guru Trades in Q1 2014

Yacktman Focused Fund 944,000 sh (unchged)
Yacktman Fund 1,096,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with SIAL

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-12-31 Add 126.77%0.05%$82.91 - $94.19 $ 94.078%41710
John Burbank 2013-09-30 Sold Out 0.05%$80.9 - $88 $ 94.0712%0
Joel Greenblatt 2013-09-30 Add 126.04%0.03%$80.9 - $88 $ 94.0712%18393
Ray Dalio 2013-09-30 Sold Out $80.9 - $88 $ 94.0712%0
Yacktman Fund 2013-06-30 Add 94.29%0.46%$74.1 - $85.14 $ 94.0718%1096000
Yacktman Focused Fund 2013-06-30 Add 94.88%0.46%$74.1 - $85.14 $ 94.0718%944000
Donald Yacktman 2013-06-30 Add 94.43%0.45%$74.1 - $85.14 $ 94.0718%2420445
Vanguard Health Care Fund 2013-06-30 Sold Out 0.15%$74.1 - $85.14 $ 94.0718%0
John Burbank 2013-06-30 New Buy0.05%$74.1 - $85.14 $ 94.0718%20000
Joel Greenblatt 2013-06-30 New Buy0.03%$74.1 - $85.14 $ 94.0718%8137
Ray Dalio 2013-06-30 New Buy$74.1 - $85.14 $ 94.0718%3227
Vanguard Health Care Fund 2013-03-31 Reduce -85.11%0.54%$73.58 - $78.95 $ 94.0722%488400
Yacktman Fund 2013-03-31 New Buy0.52%$73.58 - $78.95 $ 94.0722%564100
Yacktman Focused Fund 2013-03-31 New Buy0.51%$73.58 - $78.95 $ 94.0722%484400
Donald Yacktman 2013-03-31 New Buy0.5%$73.58 - $78.95 $ 94.0722%1244900
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Sigma-Aldrich Corporation

Weekly 52-Week Highs Highlight: MGM, SIAL, ADBE, LVS
According to GuruFocus list of 52-week highs; MGM Resorts International, Sigma-Aldrich Corp., Adobe Systems Inc. and Las Vegas Sands Corp. have all reached their 52-week highs. Read more...
The Yacktman Fund's Top 5 Second Quarter Increases
During the second quarter the Yacktman Fund added two new companies and made notable increases in five stocks. The following five companies represent the largest increases made by guru Donald Yacktman’s Yacktman Fund. [b] Read more...
Donald Yacktman Buys Wells Fargo, Oracle
After purchasing only a small parcel of shares in one company, Sigma-Aldrich Corp. (SIAL), in the first quarter for the Yacktman Focused Fund, Donald Yacktman and his team espied two values in the second quarter: Oracle Corp. (ORCL) and Wells Fargo (WFC). The total Yacktman Focused Fund contains 37 stocks and has a total value of $8.03 billion, with a quarter-over-quarter turnover of 7%. Read more...
Are Donald Yacktman's New Buys Undervalued?
Yacktman Asset Management’s Donald Yacktman looks for good, low-priced businesses that he holds for the long term. Using this strategy, he has earned prodigious returns for investors on the firm’s $22 billion in assets under management. Read more...
Texas-Sized Big Buys by Yacktman
When Texans do anything, it tends to be big. Case in point, Texan Guru Donald Yacktman of Yacktman Asset Management, and his funds bought BIG in the first quarter of 2013, according to GuruFocus Real Time Picks. Here’s a look at Yacktman’s recent buys and the P/Es of those stocks. Read more...
Why Donald Yacktman Likes Sigma-Aldrich, His Sole New Q1 Pick
Only one new stock met Austin, Texas-based investor Donald Yacktman’s rigorous standards for inclusion in his funds this past quarter: Sigma-Aldrich Corporation (SIAL), a stock whose price has been going up fairly steadily since 2009. Yacktman bought 564,100 shares for his Yacktman Fund in the first quarter, and 484,400 shares for his Yacktman Focus Fund, for $77 shares in the first quarter. A closer look at the company and Yacktman’s investment criteria suggests why he might like it. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 23.20
SIAL's P/E(ttm) is ranked higher than
54% of the 808 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 18.40 vs. SIAL: 23.20 )
SIAL' s 10-Year P/E(ttm) Range
Min: 12.12   Max: 25.63
Current: 23.2

12.12
25.63
P/B 3.87
SIAL's P/B is ranked lower than
69% of the 960 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.59 vs. SIAL: 3.87 )
SIAL' s 10-Year P/B Range
Min: 2.87   Max: 4.88
Current: 3.87

2.87
4.88
P/S 4.21
SIAL's P/S is ranked lower than
80% of the 1003 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.96 vs. SIAL: 4.21 )
SIAL' s 10-Year P/S Range
Min: 1.92   Max: 4.32
Current: 4.21

1.92
4.32
PFCF 21.04
SIAL's PFCF is ranked higher than
60% of the 493 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 19.52 vs. SIAL: 21.04 )
SIAL' s 10-Year PFCF Range
Min: 12.57   Max: 25.94
Current: 21.04

12.57
25.94
EV-to-EBIT 16.46
SIAL's EV-to-EBIT is ranked higher than
57% of the 844 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.90 vs. SIAL: 16.46 )
SIAL' s 10-Year EV-to-EBIT Range
Min: 8.8   Max: 20.2
Current: 16.46

8.8
20.2
PEG 2.58
SIAL's PEG is ranked higher than
51% of the 501 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.60 vs. SIAL: 2.58 )
SIAL' s 10-Year PEG Range
Min: 0.89   Max: 2.7
Current: 2.58

0.89
2.7
Shiller P/E 26.81
SIAL's Shiller P/E is ranked higher than
55% of the 441 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 22.21 vs. SIAL: 26.81 )
SIAL' s 10-Year Shiller P/E Range
Min: 15.13   Max: 32.49
Current: 26.81

15.13
32.49

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.90
SIAL's Dividend Yield is ranked lower than
75% of the 759 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.76 vs. SIAL: 0.90 )
SIAL' s 10-Year Dividend Yield Range
Min: 0.63   Max: 1.64
Current: 0.9

0.63
1.64
Dividend Payout 0.21
SIAL's Dividend Payout is ranked higher than
77% of the 625 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.31 vs. SIAL: 0.21 )
SIAL' s 10-Year Dividend Payout Range
Min: 0.08   Max: 0.21
Current: 0.21

0.08
0.21
Dividend growth (3y) 10.40
SIAL's Dividend growth (3y) is ranked higher than
74% of the 431 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 10.70 vs. SIAL: 10.40 )
SIAL' s 10-Year Dividend growth (3y) Range
Min: 5.3   Max: 30
Current: 10.4

5.3
30
Yield on cost (5-Year) 1.49
SIAL's Yield on cost (5-Year) is ranked lower than
58% of the 775 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 2.00 vs. SIAL: 1.49 )
SIAL' s 10-Year Yield on cost (5-Year) Range
Min: 1.04   Max: 2.71
Current: 1.49

1.04
2.71
Share Buyback Rate 0.50
SIAL's Share Buyback Rate is ranked higher than
85% of the 570 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -1.10 vs. SIAL: 0.50 )
SIAL' s 10-Year Share Buyback Rate Range
Min: 10.1   Max: -1
Current: 0.5

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 25.02
SIAL's Price/Net Current Asset Value is ranked lower than
77% of the 281 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.80 vs. SIAL: 25.02 )
SIAL' s 10-Year Price/Net Current Asset Value Range
Min: 12.01   Max: 3023
Current: 25.02

12.01
3023
Price/Tangible Book 5.74
SIAL's Price/Tangible Book is ranked lower than
74% of the 908 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.70 vs. SIAL: 5.74 )
SIAL' s 10-Year Price/Tangible Book Range
Min: 2.35   Max: 6.67
Current: 5.74

2.35
6.67
Price/DCF (Projected) 1.62
SIAL's Price/DCF (Projected) is ranked higher than
61% of the 426 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.40 vs. SIAL: 1.62 )
SIAL' s 10-Year Price/DCF (Projected) Range
Min: 1.04   Max: 2.4
Current: 1.62

1.04
2.4
Price/Median PS Value 1.35
SIAL's Price/Median PS Value is ranked lower than
58% of the 915 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.10 vs. SIAL: 1.35 )
SIAL' s 10-Year Price/Median PS Value Range
Min: 0.62   Max: 1.45
Current: 1.35

0.62
1.45
Price/Peter Lynch Fair Value 2.63
SIAL's Price/Peter Lynch Fair Value is ranked lower than
57% of the 241 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.19 vs. SIAL: 2.63 )
SIAL' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.81   Max: 4.05
Current: 2.63

0.81
4.05
Price/Graham Number 2.41
SIAL's Price/Graham Number is ranked lower than
63% of the 761 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.30 vs. SIAL: 2.41 )
SIAL' s 10-Year Price/Graham Number Range
Min: 1.25   Max: 2.59
Current: 2.41

1.25
2.59
Earnings Yield (Greenblatt) 6.10
SIAL's Earnings Yield (Greenblatt) is ranked higher than
61% of the 886 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.60 vs. SIAL: 6.10 )
SIAL' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5   Max: 11.3
Current: 6.1

5
11.3
Forward Rate of Return (Yacktman) 11.75
SIAL's Forward Rate of Return (Yacktman) is ranked higher than
82% of the 596 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.16 vs. SIAL: 11.75 )
SIAL' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 12.2   Max: 19.7
Current: 11.75

12.2
19.7

Business Description

Industry: Chemicals » Specialty Chemicals
Compare:NEU, SCL, VAL, POL, CYT » details
Traded in other countries:SIQ.Germany
Sigma-Aldrich Corporation was incorporated under the laws of the State of Delaware in May 1975. The Company is a Life Science and High Technology company. It develops, manufactures, purchases and distributes the range of high quality chemicals, biochemicals and equipment available throughout the world. These chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. On January 31, 2012, the Company acquired BioReliance Holdings, Inc. (BioReliance), a provider of global biopharmaceutical testing services. BioReliance had $126 million of sales in 2011. The Company operates in 37 countries, manufacturing approximately 50,000 of the 170,000 chemical and biochemical products it offers. The Company also offers approximately 45,000 equipment products. The Company sells into 160 countries, servicing over 97,000 accounts representing over 1.4 million individual customers. The Company provides products that focus on: research customers that use smaller quantities of its products in basic life science and high-technology research and development, and manufacturing customers that use its products in larger quantities in lab-stage development and manufacturing. It is organized into a customer-centric structure featuring the Research units of Essentials, Specialties and Biotech and a Fine Chemicals unit, SAFC. The Research Essentials unit sells biological buffers, cell culture reagents, biochemicals, chemicals, solvents, and other reagents and kits. The Research Specialties unit sells organic chemicals, biochemicals, analytical reagents, chromatography and other laboratory consumables, reference materials and high-purity products which are generally sold in smaller volumes to the lab scientist customer. The Research Biotech unit supplies immunochemical, molecular biology, cell biology, proteomic, genomic, transgenic and other life science products to academic, government, industrial, biotechnology and pharmaceutical research customers. The SAFC (Fine Chemicals) unit is a top 10 supplier of large-scale organic chemicals and biochemicals used in development and production by pharmaceutical, biotechnology, industrial, diagnostic and electronics companies. The Company's trademarks are the brand names: Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haen, Supelco, SAFC, SAFC Biosciences, SAFC Supply Solutions, SAFC Pharma, SAFC Hitech, Genosys, Proligo and Pharmorphix. In all product areas, the Company competes mainly on the basis of customer service, product availability, quality and price.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide